Over the years, she has provided legal support for the company's operations, franchises, pricing, regulatory, privacy, compliance, billing, and Quest for Health Equity. Wallace joined Quest in 2009 in the legal department as Senior Corporate Counsel. Naval Academy, an MA in National Security Studies from Georgetown University, and an MBA from the Wharton School at the University of Pennsylvania.Īs the compliance leader, Kristin Wallace is responsible for maintaining and building on Quest's industry leadership in ethics, integrity, compliance, and privacy. Navy, where he reached the rank of Lieutenant Commander. He began his private sector career as a McKinsey consultant after serving in the U.S. He built a career in molecular genomics, next generation sequencing and oncology diagnostics, having served at a range of companies that include Thermo Fisher Scientific, Life Technologies, Invitrogen and Omniseq. He joins Quest from Corza Medical, a private equity operating company focused on surgical technologies and tools, where he served as Executive Partner, SVP and GM of European Commercial Operations and Biosurgery Products. Gardner is responsible for driving growth in Quest's Advanced Diagnostics offerings by providing genetic sequencing services, cancer diagnostics and working closely with the company's clinical franchises. in electrical and biomedical engineering from Washington University in St. in finance and operations from Marquette University and a Ph.D. in biomedical engineering from the Indian Institute of Technology, both in India. in electronics and communications engineering from Anna University and a M.S. Before that, he led the Neurology franchise. Previously, he led the North region as General Manager, based at the lab in Marlborough, MA. Kuppusamy is responsible for bringing innovative diagnostic solutions to market through Quest's clinical franchises as well as Pharma Services, Genomic Services, and Global Markets, in partnership with the company's highly capable Medical and Research & Development teams. " Quest is well-positioned in the market and Jim has a great leadership team in place as we pursue the next phases of growth and development." "We have made substantial progress in our transition to new leadership, as evidenced by the strong team Jim Davis has built," said Steve Rusckowski, Chairman, CEO and President. Mark comes to Quest with deep knowledge in molecular genomics, genetic sequencing and oncology, combined with commercial and technology expertise which are critical as we drive growth in these areas." "Both Karthik and Kristin are proven Quest leaders and are ready to assume additional responsibilities within our team. "These latest appointments continue to strengthen Quest's leadership team and position us well to continue to innovate in a post-pandemic healthcare environment," said Mr. Kristin Wallace is now Senior Vice President, Compliance, succeeding Tim Sharpe, who retired in August.Mark Gardner has been appointed Senior Vice President, Molecular Genomics and Oncology, a new position.Karthik Kuppusamy, Ph.D., is named Senior Vice President, Clinical Solutions.Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |